Simultaneously the Syndol launch arrives at the same time as an editorial campaign to support pharmacy with the aim to help patients manage acute pain, organised by the Pharmaceutical Journal with the support of Reckitt Benckiser. The campaign originated with a pharmacy consultation and acute pain survey, 35% of respondents (n>1000) stated that they spoke about acute adult pain 2-5x a day. Some results suggest there is confusion around the guidance and treatment recommendations for different acute pain indications, hence the identified need for further education.
There will be three learning articles that will be published in the coming months. The first of these will explain how to understand the efficacy and safety of oral OTC analgesics in the context of acute pain relief; the second will run alongside this and explain how to correctly interpret the relevant clinical data, including the different types of studies used to assess pain. The final learning article will provide practical information on how to consult with patients, implement clinical guidance and apply the evidence base.
Through this, pharmacists will undoubtedly be able to put patients at the centre of the care pathway and promote self-care for acute pain.